Prediction of radiographic progression during a treat-to-target strategy by the sequential application of MRI-proven bone marrow oedema and power-Doppler grade ≥2 articular synovitis in rheumatoid arthritis: Retrospective observational study.

MLA

Takatani, Ayuko, et al. “Prediction of Radiographic Progression during a Treat-to-Target Strategy by the Sequential Application of MRI-Proven Bone Marrow Oedema and Power-Doppler Grade ≥2 Articular Synovitis in Rheumatoid Arthritis: Retrospective Observational Study.” Modern Rheumatology, vol. 33, no. 4, July 2023, pp. 708–14. EBSCOhost, https://doi.org/10.1093/mr/roac077.

APA

Takatani, A., Tamai, M., Ohki, N., Okamoto, M., Endo, Y., Tsuji, S., Shimizu, T., Umeda, M., Fukui, S., Sumiyoshi, R., Nishino, A., Koga, T., Kawashiri, S., Iwamoto, N., Igawa, T., Ichinose, K., Arima, K., Nakamuraa, H., Origuchia, T., & Uetani, M. (2023). Prediction of radiographic progression during a treat-to-target strategy by the sequential application of MRI-proven bone marrow oedema and power-Doppler grade ≥2 articular synovitis in rheumatoid arthritis: Retrospective observational study. Modern Rheumatology, 33(4), 708–714. https://doi.org/10.1093/mr/roac077

Chicago

Takatani, Ayuko, Mami Tamai, Nozomi Ohki, Momoko Okamoto, Yushiro Endo, Sousuke Tsuji, Toshimasa Shimizu, et al. 2023. “Prediction of Radiographic Progression during a Treat-to-Target Strategy by the Sequential Application of MRI-Proven Bone Marrow Oedema and Power-Doppler Grade ≥2 Articular Synovitis in Rheumatoid Arthritis: Retrospective Observational Study.” Modern Rheumatology 33 (4): 708–14. doi:10.1093/mr/roac077.